Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blinded, Randomized, Placebo-Controlled, Phase 2B Trial of IMC-1 for the Treatment of Fibromyalgia

NCT04748705 is registered in ClinicalTrials.gov with Virios Therapeutics, Inc. as lead sponsor.

NCT NCT04748705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04748705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blinded, Randomized, Placebo-Controlled, Phase 2B Trial of IMC-1 for the Treatment of Fibromyalgia
Lead sponsor
Virios Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
June 3, 2021
Completion date
August 5, 2022
Enrollment
422 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia